Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants, and Monoamine Oxidase Inhibitors are three types of pharmacological therapies used to treat depression. Selective Serotonin Reuptake Inhibitors work by increasing serotonin levels in the brain, Tricyclic Antidepressants affect both serotonin and norepinephrine, and Monoamine Oxidase Inhibitors prevent the breakdown of neurotransmitters like serotonin, norepinephrine, and dopamine.
Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants, and Monoamine Oxidase Inhibitors are three types of pharmacological therapies used to treat depression. Selective Serotonin Reuptake Inhibitors work by increasing serotonin levels in the brain, Tricyclic Antidepressants affect both serotonin and norepinephrine, and Monoamine Oxidase Inhibitors prevent the breakdown of neurotransmitters like serotonin, norepinephrine, and dopamine.
Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants, and Monoamine Oxidase Inhibitors are three types of pharmacological therapies used to treat depression. Selective Serotonin Reuptake Inhibitors work by increasing serotonin levels in the brain, Tricyclic Antidepressants affect both serotonin and norepinephrine, and Monoamine Oxidase Inhibitors prevent the breakdown of neurotransmitters like serotonin, norepinephrine, and dopamine.